nodes	percent_of_prediction	percent_of_DWPC	metapath
Vilazodone—SLC6A4—autistic disorder	0.734	1	CbGaD
Vilazodone—HTR1A—telencephalic ventricle—autistic disorder	0.00913	0.102	CbGeAlD
Vilazodone—DRD2—telencephalic ventricle—autistic disorder	0.00825	0.0923	CbGeAlD
Vilazodone—SLC6A4—hindbrain—autistic disorder	0.00485	0.0543	CbGeAlD
Vilazodone—HTR1A—hindbrain—autistic disorder	0.00431	0.0482	CbGeAlD
Vilazodone—DRD2—hindbrain—autistic disorder	0.00389	0.0436	CbGeAlD
Vilazodone—CYP2C18—digestive system—autistic disorder	0.00367	0.0411	CbGeAlD
Vilazodone—SLC6A4—brainstem—autistic disorder	0.00278	0.0311	CbGeAlD
Vilazodone—SLC6A4—forebrain—autistic disorder	0.00268	0.03	CbGeAlD
Vilazodone—HTR1A—brainstem—autistic disorder	0.00247	0.0276	CbGeAlD
Vilazodone—SLC6A4—telencephalon—autistic disorder	0.00247	0.0276	CbGeAlD
Vilazodone—HTR1A—forebrain—autistic disorder	0.00238	0.0267	CbGeAlD
Vilazodone—CYP2D6—hindbrain—autistic disorder	0.00234	0.0262	CbGeAlD
Vilazodone—DRD2—brainstem—autistic disorder	0.00223	0.025	CbGeAlD
Vilazodone—HTR1A—telencephalon—autistic disorder	0.00219	0.0245	CbGeAlD
Vilazodone—DRD2—eye—autistic disorder	0.00217	0.0243	CbGeAlD
Vilazodone—DRD2—forebrain—autistic disorder	0.00215	0.0241	CbGeAlD
Vilazodone—DRD2—telencephalon—autistic disorder	0.00198	0.0222	CbGeAlD
Vilazodone—Aripiprazole—HTR3A—autistic disorder	0.00197	0.196	CrCbGaD
Vilazodone—Aripiprazole—HTR1D—autistic disorder	0.00195	0.194	CrCbGaD
Vilazodone—SLC6A4—digestive system—autistic disorder	0.00188	0.0211	CbGeAlD
Vilazodone—SLC6A4—head—autistic disorder	0.00154	0.0172	CbGeAlD
Vilazodone—SLC6A4—nervous system—autistic disorder	0.00146	0.0163	CbGeAlD
Vilazodone—SLC6A4—central nervous system—autistic disorder	0.0014	0.0157	CbGeAlD
Vilazodone—HTR1A—head—autistic disorder	0.00136	0.0153	CbGeAlD
Vilazodone—CYP2D6—brainstem—autistic disorder	0.00134	0.015	CbGeAlD
Vilazodone—CYP2D6—forebrain—autistic disorder	0.00129	0.0145	CbGeAlD
Vilazodone—HTR1A—nervous system—autistic disorder	0.00129	0.0145	CbGeAlD
Vilazodone—HTR1A—central nervous system—autistic disorder	0.00125	0.0139	CbGeAlD
Vilazodone—DRD2—head—autistic disorder	0.00123	0.0138	CbGeAlD
Vilazodone—HTR1A—cerebellum—autistic disorder	0.00122	0.0136	CbGeAlD
Vilazodone—CYP2D6—telencephalon—autistic disorder	0.00119	0.0133	CbGeAlD
Vilazodone—DRD2—nervous system—autistic disorder	0.00117	0.0131	CbGeAlD
Vilazodone—Aripiprazole—HTR1B—autistic disorder	0.00116	0.115	CrCbGaD
Vilazodone—DRD2—central nervous system—autistic disorder	0.00113	0.0126	CbGeAlD
Vilazodone—Aripiprazole—DRD3—autistic disorder	0.00112	0.112	CrCbGaD
Vilazodone—SLC6A4—brain—autistic disorder	0.00111	0.0125	CbGeAlD
Vilazodone—Aripiprazole—DRD1—autistic disorder	0.0011	0.11	CrCbGaD
Vilazodone—DRD2—cerebellum—autistic disorder	0.0011	0.0123	CbGeAlD
Vilazodone—HTR1A—brain—autistic disorder	0.000989	0.0111	CbGeAlD
Vilazodone—CYP3A4—digestive system—autistic disorder	0.000923	0.0103	CbGeAlD
Vilazodone—CYP2D6—digestive system—autistic disorder	0.000908	0.0102	CbGeAlD
Vilazodone—DRD2—brain—autistic disorder	0.000894	0.01	CbGeAlD
Vilazodone—Aripiprazole—SLC6A4—autistic disorder	0.000781	0.0777	CrCbGaD
Vilazodone—Trazodone—SLC6A4—autistic disorder	0.000777	0.0773	CrCbGaD
Vilazodone—CYP2D6—head—autistic disorder	0.000741	0.00829	CbGeAlD
Vilazodone—CYP3A4—nervous system—autistic disorder	0.000714	0.00799	CbGeAlD
Vilazodone—CYP2D6—nervous system—autistic disorder	0.000702	0.00786	CbGeAlD
Vilazodone—CYP3A4—central nervous system—autistic disorder	0.000687	0.00769	CbGeAlD
Vilazodone—CYP2D6—central nervous system—autistic disorder	0.000676	0.00757	CbGeAlD
Vilazodone—CYP2D6—cerebellum—autistic disorder	0.000661	0.0074	CbGeAlD
Vilazodone—Aripiprazole—HTR2A—autistic disorder	0.0006	0.0597	CrCbGaD
Vilazodone—Trazodone—HTR2A—autistic disorder	0.000597	0.0594	CrCbGaD
Vilazodone—CYP2D6—brain—autistic disorder	0.000537	0.00601	CbGeAlD
Vilazodone—CYP3A4—Biological oxidations—GSTP1—autistic disorder	5.34e-05	0.00032	CbGpPWpGaD
Vilazodone—CYP3A4—Biological oxidations—MAOA—autistic disorder	5.32e-05	0.000319	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—OXT—autistic disorder	5.32e-05	0.000319	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—HTR1B—autistic disorder	5.32e-05	0.000319	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—TDO2—autistic disorder	5.32e-05	0.000319	CbGpPWpGaD
Vilazodone—CYP2D6—Biological oxidations—POMC—autistic disorder	5.3e-05	0.000318	CbGpPWpGaD
Vilazodone—CYP3A4—Metapathway biotransformation—COMT—autistic disorder	5.29e-05	0.000317	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—GABBR2—autistic disorder	5.28e-05	0.000317	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—CALCA—autistic disorder	5.27e-05	0.000316	CbGpPWpGaD
Vilazodone—CYP3A4—Metapathway biotransformation—GSTP1—autistic disorder	5.26e-05	0.000316	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PRLR—autistic disorder	5.16e-05	0.00031	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—DRD1—autistic disorder	5.11e-05	0.000307	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—DHCR7—autistic disorder	5e-05	0.0003	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—GRM8—autistic disorder	4.99e-05	0.000299	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—DRD3—autistic disorder	4.95e-05	0.000297	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—DRD1—autistic disorder	4.94e-05	0.000296	CbGpPWpGaD
Vilazodone—CYP3A4—Biological oxidations—GSTM1—autistic disorder	4.9e-05	0.000294	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—POMC—autistic disorder	4.88e-05	0.000293	CbGpPWpGaD
Vilazodone—HTR1A—SIDS Susceptibility Pathways—IL6—autistic disorder	4.86e-05	0.000292	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—IL5—autistic disorder	4.85e-05	0.000291	CbGpPWpGaD
Vilazodone—CYP3A4—Metapathway biotransformation—GSTM1—autistic disorder	4.84e-05	0.00029	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—HTR1B—autistic disorder	4.83e-05	0.00029	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—OXT—autistic disorder	4.83e-05	0.00029	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—WNT2—autistic disorder	4.83e-05	0.00029	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—CALCA—autistic disorder	4.79e-05	0.000287	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—DRD3—autistic disorder	4.79e-05	0.000287	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—GHR—autistic disorder	4.76e-05	0.000285	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—EXT1—autistic disorder	4.74e-05	0.000284	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—SLC6A8—autistic disorder	4.74e-05	0.000284	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HTR1D—autistic disorder	4.71e-05	0.000282	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PDE4A—autistic disorder	4.69e-05	0.000281	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—IL5—autistic disorder	4.69e-05	0.000281	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—CALCA—autistic disorder	4.63e-05	0.000278	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ACADSB—autistic disorder	4.59e-05	0.000275	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—INPP1—autistic disorder	4.59e-05	0.000275	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PRLR—autistic disorder	4.53e-05	0.000272	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—DAO—autistic disorder	4.52e-05	0.000271	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—DRD1—autistic disorder	4.49e-05	0.000269	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—ADRB2—autistic disorder	4.42e-05	0.000265	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—CYP19A1—autistic disorder	4.41e-05	0.000265	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—AVPR1A—autistic disorder	4.39e-05	0.000263	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—GRM8—autistic disorder	4.38e-05	0.000262	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—DRD3—autistic disorder	4.35e-05	0.000261	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—UPB1—autistic disorder	4.33e-05	0.00026	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—POMC—autistic disorder	4.29e-05	0.000257	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—IL5—autistic disorder	4.26e-05	0.000255	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—WNT2—autistic disorder	4.24e-05	0.000254	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—GRM5—autistic disorder	4.24e-05	0.000254	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—VIP—autistic disorder	4.24e-05	0.000254	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—CALCA—autistic disorder	4.2e-05	0.000252	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—GHR—autistic disorder	4.18e-05	0.00025	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—AVP—autistic disorder	4.15e-05	0.000249	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PDE4A—autistic disorder	4.12e-05	0.000247	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—OXTR—autistic disorder	4.11e-05	0.000246	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—COMT—autistic disorder	4.1e-05	0.000246	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—BTD—autistic disorder	4.09e-05	0.000245	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—GSTP1—autistic disorder	4.08e-05	0.000245	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—MAOA—autistic disorder	4.07e-05	0.000244	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—SCT—autistic disorder	4.06e-05	0.000244	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ASMT—autistic disorder	4.03e-05	0.000242	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GSTM5—autistic disorder	4.03e-05	0.000242	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—ADRB2—autistic disorder	4.01e-05	0.000241	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—CAT—autistic disorder	3.97e-05	0.000238	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—ADRB2—autistic disorder	3.88e-05	0.000233	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—GABBR1—autistic disorder	3.88e-05	0.000232	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—ADM—autistic disorder	3.88e-05	0.000232	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—AVPR1A—autistic disorder	3.85e-05	0.000231	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—EIF4E—autistic disorder	3.81e-05	0.000228	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—SLC25A12—autistic disorder	3.79e-05	0.000227	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PDE4B—autistic disorder	3.78e-05	0.000227	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—AVP—autistic disorder	3.77e-05	0.000226	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PLA2G4A—autistic disorder	3.75e-05	0.000225	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—GSTM1—autistic disorder	3.75e-05	0.000225	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—GRM5—autistic disorder	3.72e-05	0.000223	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—VIP—autistic disorder	3.72e-05	0.000223	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—SLC19A1—autistic disorder	3.69e-05	0.000221	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—OPRM1—autistic disorder	3.66e-05	0.000219	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—AVP—autistic disorder	3.65e-05	0.000219	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—OXTR—autistic disorder	3.61e-05	0.000216	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—GPX1—autistic disorder	3.59e-05	0.000215	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—SCT—autistic disorder	3.57e-05	0.000214	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—PLA2G4A—autistic disorder	3.54e-05	0.000213	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—ADRB2—autistic disorder	3.52e-05	0.000211	CbGpPWpGaD
Vilazodone—DRD2—Circadian rythm related genes—IL6—autistic disorder	3.49e-05	0.000209	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—TDO2—autistic disorder	3.48e-05	0.000208	CbGpPWpGaD
Vilazodone—CYP3A4—Biological oxidations—POMC—autistic disorder	3.47e-05	0.000208	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—HTR2A—autistic disorder	3.45e-05	0.000207	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—ADM—autistic disorder	3.4e-05	0.000204	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—GABBR1—autistic disorder	3.4e-05	0.000204	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—GZMB—autistic disorder	3.35e-05	0.000201	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—EIF4E—autistic disorder	3.35e-05	0.000201	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PDE4B—autistic disorder	3.32e-05	0.000199	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—MTHFR—autistic disorder	3.32e-05	0.000199	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—AVP—autistic disorder	3.31e-05	0.000198	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ADSL—autistic disorder	3.29e-05	0.000197	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—DHCR7—autistic disorder	3.27e-05	0.000196	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—OXT—autistic disorder	3.25e-05	0.000195	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HTR1B—autistic disorder	3.25e-05	0.000195	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—XDH—autistic disorder	3.22e-05	0.000193	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—OPRM1—autistic disorder	3.21e-05	0.000193	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—STX1A—autistic disorder	3.16e-05	0.00019	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—NPAS2—autistic disorder	3.16e-05	0.00019	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—HTR2A—autistic disorder	3.14e-05	0.000188	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—PLA2G4A—autistic disorder	3.11e-05	0.000187	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—SLC6A8—autistic disorder	3.1e-05	0.000186	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—EXT1—autistic disorder	3.1e-05	0.000186	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—APOE—autistic disorder	3.09e-05	0.000185	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—TCN2—autistic disorder	3.05e-05	0.000183	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—HTR2A—autistic disorder	3.03e-05	0.000182	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—PRKCB—autistic disorder	3.03e-05	0.000182	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—TSC1—autistic disorder	3.02e-05	0.000181	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—DRD1—autistic disorder	3.02e-05	0.000181	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—DAO—autistic disorder	2.96e-05	0.000177	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—GZMB—autistic disorder	2.94e-05	0.000176	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NTRK2—autistic disorder	2.94e-05	0.000176	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—DRD3—autistic disorder	2.93e-05	0.000175	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ADA—autistic disorder	2.91e-05	0.000175	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—PIK3CG—autistic disorder	2.9e-05	0.000174	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IL5—autistic disorder	2.86e-05	0.000172	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HTR1B—autistic disorder	2.85e-05	0.000171	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—OXT—autistic disorder	2.85e-05	0.000171	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—UPB1—autistic disorder	2.83e-05	0.00017	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CALCA—autistic disorder	2.83e-05	0.00017	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PIK3CG—autistic disorder	2.79e-05	0.000167	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—POMC—autistic disorder	2.76e-05	0.000165	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—HTR2A—autistic disorder	2.75e-05	0.000165	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—PRKCB—autistic disorder	2.75e-05	0.000165	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—PRKCB—autistic disorder	2.66e-05	0.000159	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—RORA—autistic disorder	2.66e-05	0.000159	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—POMC—autistic disorder	2.65e-05	0.000159	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—TSC1—autistic disorder	2.65e-05	0.000159	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—DRD1—autistic disorder	2.65e-05	0.000159	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ASMT—autistic disorder	2.63e-05	0.000158	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GSTM5—autistic disorder	2.63e-05	0.000158	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—PIK3CG—autistic disorder	2.63e-05	0.000158	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NTRK2—autistic disorder	2.58e-05	0.000155	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—DRD3—autistic disorder	2.57e-05	0.000154	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—PIK3CG—autistic disorder	2.54e-05	0.000153	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IL5—autistic disorder	2.51e-05	0.000151	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—POMC—autistic disorder	2.51e-05	0.00015	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PRL—autistic disorder	2.5e-05	0.00015	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—MAOB—autistic disorder	2.49e-05	0.000149	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CALCA—autistic disorder	2.48e-05	0.000149	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—SLC25A12—autistic disorder	2.48e-05	0.000149	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—POMC—autistic disorder	2.42e-05	0.000145	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—PRKCB—autistic disorder	2.41e-05	0.000145	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—SLC19A1—autistic disorder	2.41e-05	0.000144	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—ADRB2—autistic disorder	2.37e-05	0.000142	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—TPH2—autistic disorder	2.31e-05	0.000139	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—PIK3CG—autistic disorder	2.31e-05	0.000139	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—DPYD—autistic disorder	2.28e-05	0.000137	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—AVP—autistic disorder	2.23e-05	0.000134	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IGF2—autistic disorder	2.22e-05	0.000133	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—POMC—autistic disorder	2.2e-05	0.000132	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PRL—autistic disorder	2.19e-05	0.000132	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ADSL—autistic disorder	2.15e-05	0.000129	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CACNA1C—autistic disorder	2.12e-05	0.000127	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PTGS2—autistic disorder	2.12e-05	0.000127	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—XDH—autistic disorder	2.11e-05	0.000126	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PLA2G4A—autistic disorder	2.09e-05	0.000126	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—ADRB2—autistic disorder	2.08e-05	0.000125	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—NPAS2—autistic disorder	2.07e-05	0.000124	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—STX1A—autistic disorder	2.07e-05	0.000124	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—IL2—autistic disorder	2.04e-05	0.000122	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MEF2C—autistic disorder	2.04e-05	0.000122	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—TCN2—autistic disorder	2e-05	0.00012	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—ITGB3—autistic disorder	1.99e-05	0.000119	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—AVP—autistic disorder	1.96e-05	0.000117	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IGF2—autistic disorder	1.95e-05	0.000117	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—DHFR—autistic disorder	1.93e-05	0.000115	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ADA—autistic disorder	1.9e-05	0.000114	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HTR2A—autistic disorder	1.85e-05	0.000111	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—IL2—autistic disorder	1.85e-05	0.000111	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PTEN—autistic disorder	1.85e-05	0.000111	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PLA2G4A—autistic disorder	1.84e-05	0.00011	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—IL2—autistic disorder	1.79e-05	0.000107	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MEF2C—autistic disorder	1.79e-05	0.000107	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—TSC2—autistic disorder	1.76e-05	0.000106	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—ITGB3—autistic disorder	1.74e-05	0.000104	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—RORA—autistic disorder	1.74e-05	0.000104	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—LEP—autistic disorder	1.72e-05	0.000103	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—APOE—autistic disorder	1.72e-05	0.000103	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—MAOB—autistic disorder	1.63e-05	9.76e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HTR2A—autistic disorder	1.63e-05	9.76e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—IL2—autistic disorder	1.63e-05	9.75e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PRKCB—autistic disorder	1.62e-05	9.74e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—APC—autistic disorder	1.55e-05	9.32e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PIK3CG—autistic disorder	1.55e-05	9.32e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—TSC2—autistic disorder	1.55e-05	9.27e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—EGF—autistic disorder	1.54e-05	9.21e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—TPH2—autistic disorder	1.51e-05	9.07e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—LEP—autistic disorder	1.51e-05	9.07e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—APOE—autistic disorder	1.51e-05	9.07e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CYP19A1—autistic disorder	1.51e-05	9.04e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—DPYD—autistic disorder	1.49e-05	8.93e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—POMC—autistic disorder	1.48e-05	8.87e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PRKCB—autistic disorder	1.43e-05	8.55e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IGF1—autistic disorder	1.42e-05	8.54e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—MAPK1—autistic disorder	1.42e-05	8.49e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—COMT—autistic disorder	1.4e-05	8.41e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GSTP1—autistic disorder	1.4e-05	8.37e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—MAOA—autistic disorder	1.39e-05	8.35e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CACNA1C—autistic disorder	1.38e-05	8.3e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—APC—autistic disorder	1.37e-05	8.18e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PIK3CG—autistic disorder	1.37e-05	8.18e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CAT—autistic disorder	1.36e-05	8.14e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—SERPINE1—autistic disorder	1.35e-05	8.11e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—EGF—autistic disorder	1.35e-05	8.09e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—POMC—autistic disorder	1.3e-05	7.79e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PLA2G4A—autistic disorder	1.28e-05	7.69e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GSTM1—autistic disorder	1.28e-05	7.69e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—DHFR—autistic disorder	1.26e-05	7.55e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IGF1—autistic disorder	1.25e-05	7.49e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—MAPK1—autistic disorder	1.24e-05	7.46e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GPX1—autistic disorder	1.23e-05	7.36e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—SERPINE1—autistic disorder	1.19e-05	7.12e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—HRAS—autistic disorder	1.14e-05	6.82e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—MTHFR—autistic disorder	1.13e-05	6.8e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IL2—autistic disorder	1.09e-05	6.56e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—IL6—autistic disorder	1.09e-05	6.53e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—APOE—autistic disorder	1.06e-05	6.33e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PTEN—autistic disorder	1.03e-05	6.17e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—HRAS—autistic disorder	9.99e-06	5.99e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CYP19A1—autistic disorder	9.86e-06	5.91e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IL2—autistic disorder	9.61e-06	5.76e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—IL6—autistic disorder	9.56e-06	5.73e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PIK3CG—autistic disorder	9.52e-06	5.71e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—COMT—autistic disorder	9.17e-06	5.5e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GSTP1—autistic disorder	9.13e-06	5.47e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—MAOA—autistic disorder	9.1e-06	5.46e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—POMC—autistic disorder	9.07e-06	5.44e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PTEN—autistic disorder	9.04e-06	5.42e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CAT—autistic disorder	8.88e-06	5.32e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PLA2G4A—autistic disorder	8.39e-06	5.03e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GSTM1—autistic disorder	8.39e-06	5.03e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MAPK1—autistic disorder	8.37e-06	5.02e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GPX1—autistic disorder	8.03e-06	4.81e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—MTHFR—autistic disorder	7.41e-06	4.44e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MAPK1—autistic disorder	7.35e-06	4.41e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PTGS2—autistic disorder	7.23e-06	4.34e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—APOE—autistic disorder	6.9e-06	4.14e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HRAS—autistic disorder	6.72e-06	4.03e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IL6—autistic disorder	6.43e-06	3.86e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PTEN—autistic disorder	6.31e-06	3.78e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PIK3CG—autistic disorder	6.23e-06	3.73e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—POMC—autistic disorder	5.93e-06	3.55e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HRAS—autistic disorder	5.9e-06	3.54e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IL6—autistic disorder	5.65e-06	3.39e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PTGS2—autistic disorder	4.73e-06	2.83e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PTEN—autistic disorder	4.12e-06	2.47e-05	CbGpPWpGaD
